Search form

You are here

GlaxoSmithKline



Arthritis drug trialled as potential treatment for COVID-19

  • Dr. Andy Martin: We are conducting this study to see whether otilimab could potentially ease the effect of COVID- 19 on the lungs
  • Dr. Tim Felton: The primary end point of this study is that participants are alive and free of lung failure after 28 days — so this research is potentially life-saving
By Arab News ·

GSK pulls out of $20bn race for Pfizer consumer assets

By Reuters ·

GlaxoSmithKline wins new reprieve as Hikma’s generic Advair delayed again

By Reuters ·

Regional GlaxoSmithKline chief reveals how ‘new pharma’ is changing Gulf health care

By Frank Kane ·

Latest updates

Pakistan port activity surges as Middle East conflict diverts transshipment cargo
US lifts sanctions on Venezuela’s acting President Delcy Rodríguez
Pakistani rapper with vision loss uses music to challenge disability perceptions
Pakistan central bank allows teenagers to independently own, operate bank accounts 
Armed teenagers on patrol strike fear into Tehran residents

Recommended

Middle-East
UK defense secretary: We have more UK jets flying in the region than at any time in the last 15 years
Saudi Arabia
How Saudi Arabia’s East-West pipeline is easing the Hormuz chokehold on global oil markets
Middle-East
All eyes on Islamabad as Saudi Arabia, Egypt, Turkiye and Pakistan strive to contain Iran conflict

Search form

Print Edition
Read pdf version Subscribe now
© 2026 SAUDI RESEARCH & PUBLISHING COMPANY, All Rights Reserved And subject to Terms of Use Agreement.